{
    "clinical_study": {
        "@rank": "114345", 
        "arm_group": {
            "arm_group_label": "Lidocaine", 
            "arm_group_type": "Other"
        }, 
        "brief_summary": {
            "textblock": "The aim of this randomized double blind, placebo controlled, crossover study is to\n      investigate in a prospective way the effect of lidocaine in patients with trigeminal\n      neuralgia. Included patients will undergo four weekly sessions, two of which with lidocaine\n      (5mgs/kg) and two with placebo infusions administered over 60 minutes. Effect will be\n      measured with pain diaries and visual analogue scales."
        }, 
        "brief_title": "The Effect of Intravenous Lidocaine on Trigeminal Neuralgia", 
        "condition": "Trigeminal Neuralgia", 
        "condition_browse": {
            "mesh_term": [
                "Neuralgia", 
                "Trigeminal Neuralgia"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        (1) confirmed diagnosis of TN according to IASP definition, (2) age equal to or greater\n        than 18 years, (3) visual analogue scale (VAS) score equal to or greater than 3 (out of a\n        maximum 10), (4) DN4 score equal to or greater than 4 (out of a maximum 10), (5) having\n        received the recommended medications for TN (antiepileptics, spasmolytics,  opioids,\n        anti-inflammatory and simple analgesic drugs)  for an adequate period without therapeutic\n        results, (6) TN duration of at least 12 months, (8) no history of allergy to lidocaine,\n        (9) no history of substance abuse, (10) absence of severe psychiatric diseases, (11) not\n        being pregnant, (12) not lactating, (13) absence of severe cardiac, hepatic and renal\n        decease, and (14) be willing to provide a written informed consent to undergo the\n        experimental procedures."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "September 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01955967", 
            "org_study_id": "001"
        }, 
        "intervention": {
            "arm_group_label": "Lidocaine", 
            "intervention_name": "Lidocaine", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Lidocaine"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Effect", 
            "Lidocaine"
        ], 
        "lastchanged_date": "October 7, 2013", 
        "number_of_arms": "1", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Greece: Ethics Committee"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "September 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Pain intensity", 
            "safety_issue": "No", 
            "time_frame": "24h"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01955967"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Pain Relief & Palliative Care Center, Athens, Greece", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Pain Relief & Palliative Care Center, Athens, Greece", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2006", 
        "study_design": "Allocation: Randomized, Intervention Model: Crossover Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "September 2013"
    }
}